Grindeks and its subsidiary Kalceks announce, they will exhibit at the world’s largest pharma trade show CPhI Worldwide 2017 that will take place in Messe...
JSC Grindeks has received Russian Good Manufacturing Practice (GMP) certificate to confirm the quality system of Grindeks complies with the current legislative requirements in one...
Today, on 28 August, the JSC Grindeks submitted the non-audited consolidated financial statements for the first half-year of 2017 to “Nasdaq Riga”. Non-audited financial results...
Today, on 17 July, JSC Grindeks submitted to Nasdaq Riga the company’s Annual Report and the Corporate Social Responsibility Report for the year 2016, to...
Today, on 29 May, the JSC Grindeks submitted the non-audited consolidated financial statements for the first three months of 2017 to “Nasdaq Riga”. Non-audited financial...
Today, on 28 April, the JSC Grindeks submitted the audited consolidated financial statements of 2016 to “Nasdaq Riga”. Audited financial results indicate that in 2016...
On 26 April, which is the World Intellectual Property day, in a state-owned development finance institution ALTUM’s hall last year’s best trademark owners were congratulated....
Today, on 28 February, the JSC Grindeks submitted the non-audited consolidated financial statements of 2016 to “Nasdaq Riga”. Non-audited financial results indicate that in 2016...
JSC Tallinn Pharmaceutical Plant (Estonia) and HBM Pharma (Slovakia) have received Russian Good Manufacturing practice (GMP) certificates. Quality director of JSC Grindeks, Dr.chem. Juris Hmeļņickis...
On 20 January 2017, Central Finance and Contracting Agency (CFCA) of Republic of Latvia concluded an agreement with JSC Grindeks on the project implementation funded...
In the beginning of December in Moscow, Russia, one of the most prestigious events of pharmaceutical industry took place – Russian Pharma Awards 2016. Within...
Referring to the information published in Latvian media, which states that JSC Grindeks plans to move its manufacturing outside Latvia, we explain that the company’s...
